Publications
257
Citations
7,586
Est. group size
—
Recurring co-author estimate
Active years
44
Publishing since 1982
Sherif S. Farag conducts clinical research in blood cancers and stem cell transplantation. His work focuses on treatments for leukemias (such as acute myeloid leukemia) and multiple myeloma, and on improving the safety and outcomes of hematopoietic cell transplantation—a procedure that replaces a patient's blood-forming cells. Studies include testing drug regimens, preventing complications like graft-versus-host disease, and evaluating new targeted therapies.
Publication activity has been steady and fairly high across the decade, with notable peaks in 2020 and 2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
No award with a current end date on record.
4 earlier awards
- NIH R01CA182947May 2014 – Apr 2020 · $320k awarded
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
- NIH R01HL112669Mar 2012 – Feb 2018 · $720k awarded
Enhancing Engraftment of Cord Blood by CD26 Inhibition
- NIH R21CA141404Feb 2010 – Jan 2013 · $310k awarded
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
- NIH R01AI056318May 2004 – Apr 2010 · $589k awarded
QMS Technology to Deplete T Cell Alloreactivity
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~13 · 4% small-team papers (≤3 authors) · across 29 venues
- Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study
Transplantation · 2025
- Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study
Transplantation · 2025
- Ultrasound-Guided Occipital Nerve Block for Resistant Migraines in Multiple Sclerosis Patients: A Single-Arm Interventional Study on Efficacy and Quality of Life
QJM · 2025
- Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3
Journal of Clinical Oncology · 2024
- Region of Interest Detection in Melanocytic Skin Tumor Whole Slide Images -- Nevus & Melanoma
PubMed · 2024
- 512P Predictive biomarkers and protein specific mismatch repair (MMR) loss in gastrointestinal (GI) tumours on immune checkpoint inhibitors (ICI): Correlation with survival
Annals of Oncology · 2024
- Improved survival for myeloid malignancy patients receiving thiotepa/cyclophosphamide (TT/Cy) versus total body irradiation/cyclophosphamide (TBI/Cy) conditioning and allogeneic stem cell transplantation.
Journal of Clinical Oncology · 2024
- Thiotepa/cyclophosphamide (TT/Cy) preparative regimen for patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic stem cell transplantation.
Journal of Clinical Oncology · 2024
- A phase 2 trial of CD24Fc for prevention of graft-versus-host disease
Blood · 2023
- Toxicity and Outcomes of Thiotepa-Based Myeloablative Conditioning in Severely Obese Recipients of Allogeneic Stem Cell Transplant
Transplantation and Cellular Therapy · 2023
- NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022
Journal of the National Comprehensive Cancer Network · 2023
- Identification of Macrocyclic Peptide Families from Combinatorial Libraries Containing Noncanonical Amino Acids Using Cheminformatics and Bioinformatics Inspired Clustering
ACS Chemical Biology · 2023
- Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study
Haematologica · 2023
- Mgta-117, an Anti-CD117-Amanitin Antibody-Drug Conjugate, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics, and Pharmacodynamics Initial Findings from a Phase 1/2 Study
Transplantation and Cellular Therapy · 2023
- The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation
Therapeutic Advances in Hematology · 2023
- Blood×11
- Biology of Blood and Marrow Transplantation×9
- UNC Libraries×7
- Environmental Health Perspectives×5
- Journal of Clinical Oncology×4
- Nidhi Sharma
Medicine · The Ohio State University
- Srinivas Devarakonda
Medicine · The Ohio State University
- Don Benson
Medicine · The Ohio State University
- Don M. Benson
Medicine · The Ohio State University
- Yvonne A. Efebera
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile